BARCLAYS PLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 54 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$0
-100.0%
201
-98.9%
0.00%
Q2 2020$13,000
-38.1%
17,874
-14.3%
0.00%
Q1 2020$21,000
-78.6%
20,862
-66.9%
0.00%
Q4 2019$98,000
+66.1%
63,060
+93.5%
0.00%
Q3 2019$59,000
-9.2%
32,587
-18.3%
0.00%
Q2 2019$65,000
-90.3%
39,903
-89.4%
0.00%
Q1 2019$671,000
+41.6%
375,016
+49.4%
0.00%
Q4 2018$474,000
+5825.0%
251,004
+6322.8%
0.00%
Q2 2018$8,0003,9080.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ESSEX INVESTMENT MANAGEMENT CO LLC 1,136,282$2,148,0000.17%
EAM Investors, LLC 237,409$449,0000.12%
BARD ASSOCIATES INC 89,559$169,0000.10%
HighTower Advisors, LLC 5,260,088$9,942,0000.08%
Kore Private Wealth LLC 75,866$143,0000.04%
Regal Investment Advisors LLC 69,950$132,0000.03%
Paragon Capital Management Ltd 24,750$47,0000.02%
Alpine Global Management, LLC 45,994$87,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 67,204$127,0000.02%
BlueCrest Capital Management Ltd 113,480$214,0000.01%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders